2018
DOI: 10.1002/hec.3836
|View full text |Cite
|
Sign up to set email alerts
|

Who benefits most in disease management programs: Improving target efficiency

Abstract: Summary Disease management programs aim to reduce cost by improving the quality of care for chronic diseases. Evidence of their effectiveness is mixed. Reducing health care spending sufficiently to cover program costs has proved particularly challenging. This study uses a difference in differences design to examine the impact of a diabetes disease management program for high risk patients on preventive tests, health outcomes, and cost of care. Heterogeneity is examined along the dimensions of severity (measure… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(10 citation statements)
references
References 48 publications
(44 reference statements)
0
6
0
1
Order By: Relevance
“… There seems to be a pressing need for better structuring of the interaction with other healthcare levels and for making this more effective. Only by solving the current interface problems will it be possible to sustainably achieve the declared goal of an interlinked supply chain [ 8 , 42 , 44 , 46 ]. The implementation of better incentive and remuneration structures can help to retain patients in the programs.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“… There seems to be a pressing need for better structuring of the interaction with other healthcare levels and for making this more effective. Only by solving the current interface problems will it be possible to sustainably achieve the declared goal of an interlinked supply chain [ 8 , 42 , 44 , 46 ]. The implementation of better incentive and remuneration structures can help to retain patients in the programs.…”
Section: Discussionmentioning
confidence: 99%
“…It has been found that patients enrolled in DMPs are better informed about their disease and the associated risks, and display greater treatment compliance [ 8 , 9 , 14 ]. However, in terms of the demonstrable effects of DMPs, there are currently very few reliable efficacy studies available for the German healthcare context.…”
Section: Introductionmentioning
confidence: 99%
“…This fundamental dimension of quality of care may depend on the remuneration scheme. The literature shows that patients enrolled in a pay-forperformance (P4P) program undergo significantly more diabetes-specific examinations and tests after enrollment (Cheng, Lee, & Chen, 2012;Iezzi, Lippi Bruni, & Ugolini, 2014;Scott, Schurer, Jensen, & Sivey, 2009;Simcoe, Catillon, & Gertler, 2019). Although a P4P program may have a positive impact, such as a reduction in emergency admissions ( Van der Pol et al, 2019), the efficiency of such programs seems heterogeneous.…”
Section: Physician Remuneration and Quality Of Diabetes Carementioning
confidence: 99%
“…According to the World Health Organization (WHO, 2018), NCDs are currently responsible for more than 70% deaths worldwide. Furthermore, NCDs affect quality of life (Simcoe et al, 2019) and productivity (Magliano et al, 2018), leading to an economic burden on families, communities and countries (Krstović-Spremo et al, 2014).…”
Section: Introductionmentioning
confidence: 99%